您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > KDU731
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
KDU731
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
KDU731图片
CAS NO:1610610-48-4
包装与价格:
包装价格(元)
1mg电议
5mg电议
10mg电议
50mg电议
100mg电议

产品介绍
KDU731,具有口服活性的C. parvumPI4K抑制剂,阻断体内外隐孢子虫感染,IC50值为 25 nM。KDU731 是研究隐孢子虫引起的腹泻的有望候选药物,具有广泛的安全性。
生物活性

KDU731, an orally activeC. parvumPI4Kinhibitor with anIC50value of 25 nM, blocksCryptosporidiuminfectionin vitro and in vivo[1][2]. KDU731 is a promising drug candidate for the treatment of diarrhea caused byCryptosporidiumand meets a broad range of safety[2].

IC50& Target

PI4K

 

体内研究
(In Vivo)

KDU731 (orally administration; 7 or 10mg/kg; 16 days) has potent activity againstCryptosporidiumin immunocompromised IFN-γ KO mice and dramatically reduces oocyst shedding[2].
KDU731 (orally administration; 5 mg/kg; every 12 hours for 7 days) is tolerated in all calves, and treated calves shed significantly fewer oocysts than vehicle treated calves in their stool[2].

Animal Model:6-8 week old C57BL/6 IFN-γ-knockout mice with 10,000 oocysts[1]
Dosage:7 or 10 mg/kg
Administration:Orally administration; 7 or 10 mg/kg; 16 days
Result:Resulted in significant reduction of oocyst shedding.
Animal Model:Neonatal calves with 5 x 107oocysts[1]
Dosage:5 mg/kg
Administration:Orally administration; 5 mg/kg; every 12 hours for 7 days
Result:Resulted in significant reduction of oocyst shedding in treated calves in their stool.
分子量

396.40

性状

Solid

Formula

C22H16N6O2

CAS 号

1610610-48-4

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Powder-20°C3 years
4°C2 years
In solvent-80°C6 months
-20°C1 month
溶解性数据
In Vitro: 

DMSO : 83.33 mg/mL(210.22 mM;Need ultrasonic)

配制储备液
浓度溶剂体积质量1 mg5 mg10 mg
1 mM2.5227 mL12.6135 mL25.2270 mL
5 mM0.5045 mL2.5227 mL5.0454 mL
10 mM0.2523 mL1.2614 mL2.5227 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80℃, 6 months; -20℃, 1 month。-80℃ 储存时,请在 6 个月内使用,-20℃ 储存时,请在 1 个月内使用。